nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in HCC patients
|
Guarino, M. |
|
2014 |
46 |
S4 |
p. e137- 1 p. |
artikel |
2 |
Clinical and prognostic relevance of albumin dimers in patients with cirrhosis: A novel identified structural alteration of the molecule
|
Baldassarre, M. |
|
2014 |
46 |
S4 |
p. e130- 1 p. |
artikel |
3 |
Editorial board
|
|
|
2014 |
46 |
S4 |
p. i- 1 p. |
artikel |
4 |
Effectiveness of beta-blocker in primary prevention of variceal bleeding in patients with cirrhosis: A prospective evaluation by hepatic venous pressure gradient measurement
|
Butera, G. |
|
2014 |
46 |
S4 |
p. e141- 1 p. |
artikel |
5 |
Effects of non-selective β-blockers on hemodynamics and paracentesis induced circulatory dysfunction in patients with cirrhosis undergoing large volume paracentesis
|
Ferrarese, A. |
|
2014 |
46 |
S4 |
p. e138- 1 p. |
artikel |
6 |
Efficacy and safety of long-term therapy with Entecavir (ETV) or Tenofovir (TDF) in patients with HBV-related cirrhosis
|
Fasano, M. |
|
2014 |
46 |
S4 |
p. e140- 1 p. |
artikel |
7 |
Gut-stimulated inflammasome activation drives progression of liver injury in NASH
|
Gemini, S. |
|
2014 |
46 |
S4 |
p. e140- 1 p. |
artikel |
8 |
Healthcare costs of treating patients with overt hepatic encephalopathy in Italy
|
Roggeri, D.P. |
|
2014 |
46 |
S4 |
p. e131-e132 nvt p. |
artikel |
9 |
Hepatitis delta virus (HDV) coinfection among patients with HBsAg positive cirrhosis. An analysis the MASTER-B cohort
|
Brancaccio, G. |
|
2014 |
46 |
S4 |
p. e135- 1 p. |
artikel |
10 |
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT)
|
Zanetto, A. |
|
2014 |
46 |
S4 |
p. e138- 1 p. |
artikel |
11 |
Impact of occult HBV infection in HCC presentation in HCV-related cirrhosis
|
Coppola, N. |
|
2014 |
46 |
S4 |
p. e134- 1 p. |
artikel |
12 |
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management
|
Okolicsanyi, S. |
|
2014 |
46 |
S4 |
p. e129- 1 p. |
artikel |
13 |
Mycophenoalatemofetil monotherapy in liver transplantation
|
Zingone, F. |
|
2014 |
46 |
S4 |
p. e136- 1 p. |
artikel |
14 |
No differences of response to telaprevir based therapy in cirrhotic and non cirrhotic patients with RVR: Real life data from South Italy
|
Persico, M. |
|
2014 |
46 |
S4 |
p. e134-e135 nvt p. |
artikel |
15 |
Overexpression of the genetic effector pathway of inflammosome in peripheral blood mononucleated cells of patients with acute-on-chronic liver failure
|
Gola, E. |
|
2014 |
46 |
S4 |
p. e131- 1 p. |
artikel |
16 |
Percutaneous implant of Denver peritoneovenous shunt for treatment of refractory ascites
|
Piccirillo, M. |
|
2014 |
46 |
S4 |
p. e139- 1 p. |
artikel |
17 |
Portal vein thrombosis in cirrhosis: Predictors of successful anticoagulation therapy
|
Rodriguez-Castro, K.I. |
|
2014 |
46 |
S4 |
p. e132- 1 p. |
artikel |
18 |
Potential net health benefit of pre-transplant Sofosbuvir to prevent recurrence of HCV infection after liver transplantation: A multicenter, cohort model study
|
Vitale, A. |
|
2014 |
46 |
S4 |
p. e132-e133 nvt p. |
artikel |
19 |
Quality of sleep in patients with liver transplantation
|
Zingone, F. |
|
2014 |
46 |
S4 |
p. e137- 1 p. |
artikel |
20 |
Reappraisal of prognostic value of MELD-Na score: A new tool for liver transplant prioritization in HCV-infected patients
|
Bruno, S. |
|
2014 |
46 |
S4 |
p. e129-e130 nvt p. |
artikel |
21 |
The impact of nucleoside/nucleotide analogues on the natural history of patients with HBV-related cirrhosis: A prospective comparative study towards patients with HCV-related cirrhosis in the interferon and ribavirin era
|
Piano, S. |
|
2014 |
46 |
S4 |
p. e141- 1 p. |
artikel |
22 |
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene
|
Bronte, F. |
|
2014 |
46 |
S4 |
p. e136-e137 nvt p. |
artikel |
23 |
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis
|
Cardinale, V. |
|
2014 |
46 |
S4 |
p. e139-e140 nvt p. |
artikel |
24 |
Treatment type is an independent prognostic factor for patients with intermediate stage hepatocellular carcinoma
|
Pecorelli, A. |
|
2014 |
46 |
S4 |
p. e131- 1 p. |
artikel |
25 |
Tumorigenic potential of cancer stem cells (CSCs) isolated from human cholangiocarcinoma (CCA) subtypes in cirrhotic liver
|
Torrice, A. |
|
2014 |
46 |
S4 |
p. e133- 1 p. |
artikel |